Filler and Mai developed an abbreviated pharmacokinetic protocol for monitoring serum levels of mycophenolic acid (MPA), which is the active component of the immunosuppressive agent mycophenolate mofetil (MMF). This can provide a reasonable pharmacokinetic profile with a minimum of samples. The authors are from the Children's Hospitals of Eastern Ontario.